Hydroxychloroquine in outpatient adults with COVID-19

Trial Identifier: EFC16855
Sponsor: sanofi
Start Date: April 2020
Primary Completion Date: May 2020
Study Completion Date: May 2020
Condition: Coronavirus Infection

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
BELGIUM Bruxelles, BELGIUM, BE-1200
BELGIUM Lodelinsart, BELGIUM, 6042
FRANCE Bordeaux Cedex, FRANCE, 33076
FRANCE Paris, FRANCE, 75005
NETHERLANDS Groningen, NETHERLANDS, 9728 NZ
NETHERLANDS Harderwijk, NETHERLANDS, 3844 DG
UNITED STATES, Massachusetts Boston, Massachusetts, UNITED STATES, 02115